Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Diana Julie Leeming (Herlev, Denmark), Diana Julie Leeming, Inger Byrjalsen, Jannie M.B. Sand, Asger Bihlet, Ruth Tal-Singer, Bruce E. Miller, Morten A. Karsdal, Jørgen Vestbo. LATE-BREAKING ABSTRACT: Biomarkers of tissue turnover are related to annual change in FEV1 in patients with COPD within the ECLIPSE cohort. Eur Respir J 2015; 46: Suppl. 59, 3988

Member's Comments

No comment yet.

Related content which might interest you: LATE-BREAKING ABSTRACT: Biomarkers of extracellular matrix turnover predict mortality in the ECLIPSE COPD cohort Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 LATE-BREAKING ABSTRACT: The effect of beta2-agonist on lung clearance index in COPD patients Source: International Congress 2015 – Lung function: new findings and approaches Year: 2015 LATE-BREAKING ABSTRACT: Biomarkers of ECM turnover and clinical relevant outcomes in COPD: Results of the multicenter PROMISE study Source: International Congress 2015 – Notable abstracts in COPD: variety Year: 2015 LATE-BREAKING ABSTRACT: Predictors of lung function decline in a cohort of subjects with severe asthma Source: International Congress 2015 – Monitoring airway diseases with lung function tests Year: 2015 LATE-BREAKING ABSTRACT: Tiotropium efficacy and exacerbation risk in patients with different blood eosinophil levels Source: International Congress 2015 – Emerging strategies for airway disease treatments Year: 2015 LATE-BREAKING ABSTRACT: Validation of the DECAF score to predict hospital mortality in exacerbations of COPD Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 Laboratory and clinical parameters in predicting risk of future exacerbations in both non-smoking and smoking COPD patients Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Relationship of baseline or annual change of clinical parameters on mortality in patients with COPD Source: Annual Congress 2013 –Risk factors for COPD and lung function decline Year: 2013 Lung clearance index is increased in patients with COPD Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 LATE-BREAKING ABSTRACT: Elevated cardiovascular risk as measured by QRISK2 score in patients hospitalized for acute COPD exacerbation versus stable COPD outpatients Source: International Congress 2014 – Comorbidities Year: 2014 Biomarkers in COPD exacerbation, the role of adiponectin Source: International Congress 2014 – Predictors Year: 2014 LATE-BREAKING ABSTRACT: Stability of blood eosinophil count in COPD patients in the UK clinical practice research datalink Source: International Congress 2015 – Treatment and control of respiratory disease Year: 2015 Fibrinogen and CRP biomarkers in patients with exacerbation of COPD group C and D Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 LATE-BREAKING ABSTRACT: The Guangzhou COPD exacerbation study: relationship of exacerbations with viral infections and soluble biomarkers Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 LATE-BREAKING ABSTRACT: Exacerbation phenotype directed corticosteroid therapy of COPD: Value of blood eosinophilia (primary results) Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice Year: 2015 LATE-BREAKING ABSTRACT: beta-blockers are associated with a reduction in COPD exacerbations in COPDGene Source: International Congress 2014 – COPD exacerbations Year: 2014 Stable state MR-proadrenomedullin level in COPD patients; a validation study Source: International Congress 2014 – Comorbidities Year: 2014 Changes in lung function and comorbidity in patients with COPD over 4 to 10 years of follow-up Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement Year: 2013 Estimation of a disease progression model for COPD using data from the ECLIPSE study Source: Annual Congress 2013 –Health economics of airway diseases Year: 2013 Can red blood cell morphology be an indicator for COPD exacerbations? Source: International Congress 2014 – Markers Year: 2014